| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kuo Hui Ying | Director | C/O CAPSOVISION, INC., 18805 COX AVENUE, SUITE 250, SARATOGA | /s/ Tai Vivatvaraphol, Attorney-in-Fact for Hui Ying Kuo | 07 Jul 2025 | 0002074262 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CV | Common Stock | Conversion of derivative security | +10,354 | 10,354 | 03 Jul 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CV | Series H Preferred Stock | Conversion of derivative security | $0 | -34,482 | -100% | $0.000000 | 0 | 03 Jul 2025 | Common Stock | 10,354 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Each share of Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering. |